A promising new therapeutic target for MASLD identified

Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by drugs to reduce fat accumulation in patients with a common form of fatty liver disease known as metabolic dysfunction-associated steatotic liver disease, or MASLD.

LinkedUp, TianTi end legal dispute with Adimab over yeast-based antibody platform

LinkedUp Bioscience and TianTi Biotherapeutics have resolved their legal battle with Adimab dating back to 2020 concerning alleged misuse of trade secrets. The defendants, both

January 11, 2024

Hyperbaric Oxygen Therapy Shows Some Benefit After Breast Cancer Irradiation

Hyperbaric oxygen therapy (HBOT) was not effective for reducing pain, but was effective for reducing fibrosis, among women with late local toxic effects after irradiation

February 9, 2024

The time has come for over-the-counter antidepressants

Anyone can now walk into a pharmacy in the United States and buy oral contraceptives over the counter without a prescription, thanks to the FDA’s

April 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.